KEVIN D FREEMAN
CIK 1522478 · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$361.2K
Companies
2
Total Filings
51
Lifetime Open-Market Net
$389.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALT | Director | 135,269 | $2.67 | $361.2K | $368.6K | 42 | 2026-01-21 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | Director | 29,726 | — | — | $20.6K | 7 | 2016-12-19 |
Recent Filings · Page 2 of 6
51 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-04-22 | GALT | Buy (P) | +2,500 | $7.5K | EDGAR |
| 2024-04-09 | GALT | Will (W) | +2,063 | $0 | EDGAR |
| 2024-02-07 | GALT | Grant (A) | — | $0 | EDGAR |
| 2023-01-30 | GALT | Grant (A) | — | $0 | EDGAR |
| 2022-10-31 | GALT | Buy (P) | +10,000 | $14.1K | EDGAR |
| 2022-05-20 | GALT | Buy (P) | +5,000 | $6.6K | EDGAR |
| 2022-04-18 | GALT | Buy (P) | +5,000 | $8.6K | EDGAR |
| 2022-01-25 | GALT | Grant (A) | — | $0 | EDGAR |
| 2022-01-19 | GALT | Buy (P) | +5,000 | $9.8K | EDGAR |
| 2022-01-19 | GALT | Buy (P) | +5,000 | $9.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.